EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCY
- 1 July 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 322 (8342) , 119-124
- https://doi.org/10.1016/s0140-6736(83)90113-7
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MANThe Lancet, 1983
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused AcromegalyScience, 1982
- Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumorBiochemistry, 1982
- characterization of A 40 residue peptide from a human pancreatic tumor with growth hormone releasing activityBiochemical and Biophysical Research Communications, 1982
- Characterization of a growth hormone-releasing factor from a human pancreatic islet tumourNature, 1982
- Somatotroph HyperplasiaJournal of Clinical Investigation, 1982
- Pitfalls in the Somatomedin-C Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1982
- Estimation of Somatomedin-C Levels in Normals and Patients with Pituitary Disease by RadioimmunoassayJournal of Clinical Investigation, 1977
- Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormoneJournal of Clinical Investigation, 1972
- Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormoneJournal of Clinical Investigation, 1971